Kaleido BioSciences, Inc. (OTC:KLDO)
Industry: Technology

OFF LIST - 1018 consecutive market days: OFF LIST as of 05/18/2012 Through 11/14/2016

Kaleido BioSciences, Inc. develops microbiome metabolic therapies. It offers treatment for hyperammonemia, a metabolic condition generally characterized by elevated levels of ammonia in the blood; infections caused by multi-drug resistant bacteria; chronic kidney disease; atherosclerotic cardiovascular disease; and drug or disease induced diarrhea. The company was founded in 2015 and is headquartered in Lexington, Massachusetts.

Current Quote*
Last: $9.170
Change: -0.110
Book: $3.221
Volume: 32,611

As Of: 08/22 13:17 ET
*Quotes delayed by 20min.

Graphs for KLDO


3 Month Graph


6 Month Graph


1 Year Graph